117 related articles for article (PubMed ID: 6452036)
1. Growth hormone secretion in neurological disorders.
Martinez-Campos A; Giovannini P; Cocchi D; Zanardi P; Parati EA; Caraceni T; Müller EE
Adv Biochem Psychopharmacol; 1981; 28():521-40. PubMed ID: 6452036
[No Abstract] [Full Text] [Related]
2. Regulatory peptides in animal paradigms of neuropsychiatric illness.
Diamond BI; Borison RL
Adv Biochem Psychopharmacol; 1982; 33():541-8. PubMed ID: 6214928
[No Abstract] [Full Text] [Related]
3. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
Müller T; Welnic J; Woitalla D; Muhlack S
Neurosci Lett; 2007 Jul; 422(2):119-22. PubMed ID: 17590511
[TBL] [Abstract][Full Text] [Related]
4. Role of dopaminergic receptors in the regulation of growth hormone secretion.
Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
[No Abstract] [Full Text] [Related]
5. Current concepts of abnormal motor disorder: an experimental model of attentional deficit disorder.
Wray SR; Melville GN; Grell GA; Edge PC
West Indian Med J; 1981 Sep; 30(3):107-18. PubMed ID: 6117153
[No Abstract] [Full Text] [Related]
6. [Effect of carbidopa and L-dopa combination on the secretion of growth hormone in normal subjects and in patients with Parkinsonism].
Nurzia A; Vacca U; Pirro R; Cerone G
Clin Ter; 1975 Aug; 74(3):265-70. PubMed ID: 1227747
[No Abstract] [Full Text] [Related]
7. Pre- and postsynaptic action of bromocriptine: its pharmacological effects on shcizophrenia and neurological diseases.
Trabucchi M; Andreoli VM; Frattola L; Spano PF
Adv Biochem Psychopharmacol; 1977; 16():661-5. PubMed ID: 196497
[No Abstract] [Full Text] [Related]
8. The endocrinology of extrapyramidal system disorders.
Kirkpatrick B; Tamminga CA
Endocrinol Metab Clin North Am; 1988 Mar; 17(1):159-72. PubMed ID: 2967753
[TBL] [Abstract][Full Text] [Related]
9. [Dopaminergic control of the diencephalo-pituitary axis for somatotropin secretion].
Cavagnini F; Pontiroli AE; Raggi U; Peracchi M; Malinverni A
Folia Endocrinol; 1973 Dec; 26(6):483-9. PubMed ID: 4801258
[No Abstract] [Full Text] [Related]
10. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
Antal A; Bodis-Wollner I
Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
[TBL] [Abstract][Full Text] [Related]
11. Prolactin secretion as an index of brain dopaminergic function.
Thorner MO; Login IS
Adv Biochem Psychopharmacol; 1981; 28():503-20. PubMed ID: 6452035
[No Abstract] [Full Text] [Related]
12. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
Hornykiewicz O
Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131
[No Abstract] [Full Text] [Related]
13. [Voice disorders caused by neurological diseases].
Gamboa J; Jiménez-Jiménez FJ; Mate MA; Cobeta I
Rev Neurol; 2001 Jul 16-31; 33(2):153-68. PubMed ID: 11562877
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic and serotonergic regulation of growth hormone secretion in anorexia nervosa [proceedings].
Halmi K; Sherman BS
Psychopharmacol Bull; 1977 Jan; 13(1):63-5. PubMed ID: 319476
[No Abstract] [Full Text] [Related]
15. Is dopaminergic cell death accompanied by concomitant nerve plasticity?
Anglade P; Blanchard V; Raisman-Vozari R; Faucheux BA; Herrero MT; Obeso JA; Mouatt-Prigent A; Kastner A; Strada O; Javoy-Agid F; Agid Y; Hirsch EC
Adv Neurol; 1996; 69():195-208. PubMed ID: 8615129
[No Abstract] [Full Text] [Related]
16. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice.
St-Hilaire M; Bourhis E; Lévesque D; Rouillard C
Eur J Neurosci; 2006 Aug; 24(3):795-805. PubMed ID: 16930409
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin: role in psychiatric and neurological diseases.
Cáceda R; Kinkead B; Nemeroff CB
Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
[TBL] [Abstract][Full Text] [Related]
18. [Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
Destée A; Petit H; Fossati P; Warot P
Rev Neurol (Paris); 1981; 137(1):21-31. PubMed ID: 6453416
[No Abstract] [Full Text] [Related]
19. Neuroendocrinological studies of Parkinson disease.
Kito S; Itoga E; Yamamoto M
Hiroshima J Med Sci; 1984 Sep; 33(3):323-9. PubMed ID: 6511457
[No Abstract] [Full Text] [Related]
20. Dopamine dysregulation syndrome in Parkinson's disease patients: from reward to penalty.
Bonci A; Singh V
Ann Neurol; 2006 May; 59(5):733-4. PubMed ID: 16634013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
